Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

A Common Tumour Specific Antigen

I. Restriction in vivo to Malignant Neoplastic Tissue

Abstract

(1) The antigenic activity of basic protein extracts of a variety of human tissues towards sensitized lymphocytes from cancer patients has been studied using the macrophage electrophoretic migration method.

(2) Basic protein prepared from human tumour tissue has antigenic properties which differ from basic protein prepared from normal tissues, from hyperplastic tissue and even tumour bearing host tissue.

(3) Tumour type antigenic molecules are at least 104 times less numerous on normal cells than on tumour cells. If our reasoning is accepted then they are absent from normal cells, and thus restricted in vivo to malignant cells.

(4) Hyperplastic tissues (gynaecomastia, etc.) do not contain cancer basic protein.

(5) Human chronic lymphatic leukaemic leucocytes possess the same type of cancer antigenic activity as solid tumours. This antigenic activity is not shared by normal lymphocytes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dickinson, J., Caspary, E. & Field, E. A Common Tumour Specific Antigen. Br J Cancer 27, 99–105 (1973). https://doi.org/10.1038/bjc.1973.13

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1973.13

This article is cited by

Search

Quick links